PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI)

CUSIP: 74587V107

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock
Shares outstanding
49,633,071
Total 13F shares
30,286,741
Share change
-2,904,846
Total reported value
$92,179,926
Put/Call ratio
50%
Price per share
$3.04
Number of holders
96
Value change
-$39,504,988
Number of buys
52
Number of sells
67

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 74587V107?
CUSIP 74587V107 identifies PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
7.3%
3,629,433
$25,442,000 30 Sep 2021
13F
Camber Capital Management LP
13F
Company
6.9%
3,425,000
$24,009,000 30 Sep 2021
13F
BlackRock Finance, Inc.
13F
Company
6.5%
3,207,661
$22,485,000 30 Sep 2021
13F
FRED ALGER MANAGEMENT, LLC
13F
Company
5%
2,470,965
$17,322,000 30 Sep 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
3.4%
1,666,785
$11,684,000 30 Sep 2021
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
3.3%
1,631,935
$11,440,000 30 Sep 2021
13F
Palo Alto Investors LP
13F
Company
2.8%
1,392,997
$9,765,000 30 Sep 2021
13F
GREAT POINT PARTNERS LLC
13F
Company
2.6%
1,300,000
$9,113,000 30 Sep 2021
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
2.6%
1,299,547
$9,106,000 30 Sep 2021
13F
AIGH Capital Management LLC
13F
Company
1.7%
864,427
$6,059,000 30 Sep 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.6%
807,926
$5,664,000 30 Sep 2021
13F
STATE STREET CORP
13F
Company
1.3%
637,720
$4,470,000 30 Sep 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.2%
607,151
$4,256,000 30 Sep 2021
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
1.1%
550,700
$3,860,000 30 Sep 2021
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
1.1%
546,308
$3,830,000 30 Sep 2021
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.89%
443,081
$3,106,000 30 Sep 2021
13F
GLOBEFLEX CAPITAL L P
13F
Company
0.83%
413,692
$2,900,000 30 Sep 2021
13F
Eversept Partners, LP
13F
Company
0.8%
397,940
$2,789,559 30 Sep 2021
13F
Russell Investments Group, Ltd.
13F
Company
0.73%
362,671
$2,540,000 30 Sep 2021
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.72%
359,695
$2,521,000 30 Sep 2021
13F
NORTHERN TRUST CORP
13F
Company
0.7%
349,802
$2,452,000 30 Sep 2021
13F
FEDERATED HERMES, INC.
13F
Company
0.6%
297,203
$2,083,000 30 Sep 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.59%
293,874
$2,059,000 30 Sep 2021
13F
SEI INVESTMENTS CO
13F
Company
0.55%
271,923
$1,904,000 30 Sep 2021
13F
BANK OF MONTREAL /CAN/
13F
Company
0.51%
252,988
$1,847,000 30 Sep 2021
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.52%
257,426
$1,805,000 30 Sep 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.52%
256,945
$1,802,000 30 Sep 2021
13F
MORGAN STANLEY
13F
Company
0.46%
229,236
$1,607,000 30 Sep 2021
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.43%
214,200
$1,502,000 30 Sep 2021
13F
CITADEL ADVISORS LLC
13F
Company
0.4%
199,908
$1,402,000 30 Sep 2021
13F
Worth Venture Partners, LLC
13F
Company
0.4%
197,960
$1,388,000 30 Sep 2021
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.39%
195,814
$1,373,000 30 Sep 2021
13F
JPMORGAN CHASE & CO
13F
Company
0.3%
148,940
$1,044,000 30 Sep 2021
13F
AlphaCentric Advisors LLC
13F
Company
0.3%
148,500
$1,041,000 30 Sep 2021
13F
LOS ANGELES CAPITAL MANAGEMENT LLC
13F
Company
0.29%
142,941
$1,002,000 30 Sep 2021
13F
ENVESTNET ASSET MANAGEMENT INC
13F
Company
0.27%
135,226
$948,000 30 Sep 2021
13F
Bank of New York Mellon Corp
13F
Company
0.24%
119,681
$839,000 30 Sep 2021
13F
ExodusPoint Capital Management, LP
13F
Company
0.23%
114,517
$803,000 30 Sep 2021
13F
TRUIST FINANCIAL CORP
13F
Company
0.22%
109,902
$770,000 30 Sep 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.22%
109,269
$754,000 30 Sep 2021
13F
STRS OHIO
13F
Company
0.21%
106,600
$747,000 30 Sep 2021
13F
HRT FINANCIAL LP
13F
Company
0.2%
100,111
$701,000 30 Sep 2021
13F
Squarepoint Ops LLC
13F
Company
0.2%
99,357
$696,000 30 Sep 2021
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.17%
86,040
$603,000 30 Sep 2021
13F
VIRGINIA RETIREMENT SYSTEMS ET Al
13F
Company
0.17%
85,600
$600,000 30 Sep 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.16%
80,652
$566,000 30 Sep 2021
13F
MACQUARIE GROUP LTD
13F
Company
0.14%
68,248
$478,000 30 Sep 2021
13F
PDT Partners, LLC
13F
Company
0.13%
66,728
$468,000 30 Sep 2021
13F
Swiss National Bank
13F
Company
0.13%
66,530
$466,000 30 Sep 2021
13F
BARCLAYS PLC
13F
Company
0.13%
63,643
$446,000 30 Sep 2021
13F

Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q4 2021

As of 31 Dec 2021, PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by 96 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,286,741 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., GOLDMAN SACHS GROUP INC, Camber Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, Eversept Partners, LP, JACOBS LEVY EQUITY MANAGEMENT, INC, and D. E. Shaw & Co., Inc.. This page lists 96 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
112
Q4 2021 holders
96
Holder diff
-16
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 Value $ Q4 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.